Disclosures for "The Small Molecule VQ-101 Demonstrates Sustained Lysosomal Glucocerebrosidase (GCase) Activation in Idiopathic Parkinson’s Disease"
-
Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
-
Dr. Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Varian Noona Medical Advisory Board. Dr. Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Varian Medical System. The institution of Dr. Siddiqui has received research support from Varian Medical System.
-
Mr. van der Valk has received personal compensation for serving as an employee of Centre for Human Drug Research.
-
Miss Koopmans has received personal compensation for serving as an employee of Foundation The Centre for Human Drug Research.
-
Dr. Hunt has received personal compensation for serving as an employee of Vanqua Bio.
-
Mrs. Hagey has received personal compensation for serving as an employee of Vanqua Bio. Mrs. Hagey has stock in Vanqua Bio.
-
Mr. Beyer has received personal compensation for serving as an employee of Vanqua Bio. Mr. Beyer has stock in Vanqua Bio.
-
Mrs. Wong has nothing to disclose.
-
Dr. Kremer has received personal compensation for serving as an employee of Foundation The Centre for Human Drug Research.
-
Dr. Sullivan has a non-compensated relationship as a Advisor with MigraLearn.ai that is relevant to AAN interests or activities.
-
Dr. Ysselstein has received personal compensation for serving as an employee of Vanqua Bio.